000 02050 a2200589 4500
005 20250517004457.0
264 0 _c20150819
008 201508s 0 0 eng d
022 _a1873-6815
024 7 _a10.1016/j.exger.2014.10.011
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPascual, A C
245 0 0 _aNormal aging in rats and pathological aging in human Alzheimer's disease decrease FAAH activity: modulation by cannabinoid agonists.
_h[electronic resource]
260 _bExperimental gerontology
_cDec 2014
300 _a92-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAging
_xmetabolism
650 0 4 _aAlzheimer Disease
_xdrug therapy
650 0 4 _aAmidohydrolases
_xantagonists & inhibitors
650 0 4 _aAmyloid beta-Peptides
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aArachidonic Acids
_xmetabolism
650 0 4 _aBenzamides
_xpharmacology
650 0 4 _aBenzoxazines
_xpharmacology
650 0 4 _aCannabinoid Receptor Agonists
_xpharmacology
650 0 4 _aCannabinoids
_xpharmacology
650 0 4 _aCarbamates
_xpharmacology
650 0 4 _aCase-Control Studies
650 0 4 _aCerebral Cortex
_xdrug effects
650 0 4 _aEndocannabinoids
_xmetabolism
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aFemale
650 0 4 _aFrontal Lobe
_xdrug effects
650 0 4 _aHumans
650 0 4 _aIn Vitro Techniques
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMorpholines
_xpharmacology
650 0 4 _aNaphthalenes
_xpharmacology
650 0 4 _aPolyunsaturated Alkamides
_xmetabolism
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aSynaptosomes
_xdrug effects
700 1 _aMartín-Moreno, A M
700 1 _aGiusto, N M
700 1 _ade Ceballos, M L
700 1 _aPasquaré, S J
773 0 _tExperimental gerontology
_gvol. 60
_gp. 92-9
856 4 0 _uhttps://doi.org/10.1016/j.exger.2014.10.011
_zAvailable from publisher's website
999 _c24411123
_d24411123